Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Diakomanolis

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 30, 2005
The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal womenM Papaefthimiou, H Symiakaki, P Mentzelopoulou, et al.
European Journal of Gynaecological Oncology|March 23, 2004
The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapyA Protopapas, E Diakomanolis, A Bamias, et al.
Oncology|February 9, 1999
Detection and clinical correlations of ras gene mutations in human ovarian tumorsM N Varras, G Sourvinos, E Diakomanolis, et al.
Cancer|June 15, 1997
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixC A Papadimitriou, M A Dimopoulos, N Giannakoulis, et al.
Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.
Cancer|December 18, 2001
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancerC A Papadimitriou, C Kouroussis, L A Moulopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervixC A Papadimitriou, K Sarris, L A Moulopoulos, et al.
European Journal of Gynaecological Oncology|December 9, 2003
Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasiaE Paraskevaidis, S N Kalantaridou, M Paschopoulos, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 30, 2005
The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal womenM Papaefthimiou, H Symiakaki, P Mentzelopoulou, et al.
European Journal of Gynaecological Oncology|March 23, 2004
The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapyA Protopapas, E Diakomanolis, A Bamias, et al.
Oncology|February 9, 1999
Detection and clinical correlations of ras gene mutations in human ovarian tumorsM N Varras, G Sourvinos, E Diakomanolis, et al.
Cancer|June 15, 1997
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixC A Papadimitriou, M A Dimopoulos, N Giannakoulis, et al.
Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.
Cancer|December 18, 2001
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancerC A Papadimitriou, C Kouroussis, L A Moulopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervixC A Papadimitriou, K Sarris, L A Moulopoulos, et al.
European Journal of Gynaecological Oncology|December 9, 2003
Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasiaE Paraskevaidis, S N Kalantaridou, M Paschopoulos, et al.
Pageof 4